143 related articles for article (PubMed ID: 34628069)
1. Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC.
Lv T; Huang J; Wu M; Wang H; Zeng Q; Wang X
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102572. PubMed ID: 34628069
[TBL] [Abstract][Full Text] [Related]
2. Acitretin enhances the cytotoxic effect of 5-aminolevulinic acid photodynamic therapy on squamous cell carcinoma cells.
Ye T; Li D; Yang L; Liu X; Jiang B; Chen B; Zou Y; Yu B
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102969. PubMed ID: 35714900
[TBL] [Abstract][Full Text] [Related]
3. 5-aminolevulinic acid photodynamic therapy inhibits invasion and metastasis of SCL-1 cells probably via MTSS1 and p63 gene related pathways.
Ye T; Chen T; Jiang B; Yang L; Liu X; Chen B; Zou Y; Yu B
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102039. PubMed ID: 33017656
[TBL] [Abstract][Full Text] [Related]
4. Modified 5-aminolevulinic acid photodynamic therapy reduces pain and improves therapeutic effects in cutaneous squamous cell carcinoma mouse model.
Zeng Q; Zhou C; Zhang Y; Yan G; Wang X
Lasers Surg Med; 2022 Jul; 54(5):804-812. PubMed ID: 35066886
[TBL] [Abstract][Full Text] [Related]
5. Modified 5-aminolevulinic acid photodynamic therapy (M-PDT) inhibits cutaneous squamous cell carcinoma cell proliferation via targeting PP2A/PP5-mediated MAPK signaling pathway.
Liu J; Yan G; Chen Q; Zeng Q; Wang X
Int J Biochem Cell Biol; 2021 Aug; 137():106036. PubMed ID: 34217813
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin administration improves the effectiveness of 5-aminolevulinic acid-mediated photodynamic therapy for the treatment of high-risk human papillomavirus infection.
Li Z; Teng M; Wang Y; Feng Y; Xiao Z; Hu H; Wang Q; Lu Y; Li C; Zeng K; Yang B
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102078. PubMed ID: 33157332
[TBL] [Abstract][Full Text] [Related]
7. CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.
Ji J; Wang P; Zhou Q; Zhu L; Zhang H; Zhang Y; Zheng Z; Bhatta AK; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2019 Jun; 26():235-243. PubMed ID: 30902794
[TBL] [Abstract][Full Text] [Related]
8. The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy.
Zhu L; Zhang G; Wang P; Zhang L; Ji J; Liu X; Zhou Z; Zhao J; Wang X
Photodiagnosis Photodyn Ther; 2019 Jun; 26():389-394. PubMed ID: 31022580
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
[TBL] [Abstract][Full Text] [Related]
10. lncRNA TINCR participates in ALA-PDT-induced apoptosis and autophagy in cutaneous squamous cell carcinoma.
Zhou W; Zhang S; Li J; Li Z; Wang Y; Li X
J Cell Biochem; 2019 Aug; 120(8):13893-13902. PubMed ID: 30993776
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
12. 5-aminolevulinic acid photodynamic therapy enhance the effect of acitretin on squamous cell carcinoma cells: An in vitro study.
Ye T; Jiang B; Chen B; Liu X; Yang L; Xiong W; Yu B
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101887. PubMed ID: 32565180
[TBL] [Abstract][Full Text] [Related]
13. The effect of ALA-PDT on reversing the activation of cancer-associated fibroblasts in cutaneous squamous cell carcinoma.
Li S; Wang P; Zhang G; Ji J; Lv T; Wang X; Wang H
Photodiagnosis Photodyn Ther; 2019 Sep; 27():234-240. PubMed ID: 31163284
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of gene expression changes in murine cutaneous squamous cell carcinoma after 5-aminolevulinic acid photodynamic therapy.
Fang S; Wu Y; Zhang H; Zeng Q; Wang P; Zhang L; Yan G; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102907. PubMed ID: 35569747
[TBL] [Abstract][Full Text] [Related]
15. 5-aminolevulinic acid sonodynamic therapy for cutaneous squamous cell carcinoma.
Li C; Yan J; Wang P; Zhang H; Zeng Q; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103801. PubMed ID: 37717674
[TBL] [Abstract][Full Text] [Related]
16. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-tumor efficacy of 5-aminolevulinic acid-gold nanoparticles-mediated photodynamic therapy in cutaneous squamous cell carcinoma cells.
Chi YF; Qin JJ; Li Z; Ge Q; Zeng WH
Braz J Med Biol Res; 2020; 53(5):e8457. PubMed ID: 32348428
[TBL] [Abstract][Full Text] [Related]
18. Effects of photodynamic therapy using Red LED-light combined with hypocrellin B on apoptotic signaling in cutaneous squamous cell carcinoma A431 cells.
Liu Y; Cao Z; Wei G
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103683. PubMed ID: 37390854
[TBL] [Abstract][Full Text] [Related]
19. Influence and mechanism of 5-aminolevulinic acid-photodynamic therapy on the metastasis of esophageal carcinoma.
Zhang X; Cai L; He J; Li X; Li L; Chen X; Lan P
Photodiagnosis Photodyn Ther; 2017 Dec; 20():78-85. PubMed ID: 28811223
[TBL] [Abstract][Full Text] [Related]
20. In vitro modeling of recurrent Dermatofibrosarcoma Protuberans: Assessment of 5-aminolevulinic acid photodynamic therapy efficacy.
Jiang H; He K; Tan J; Zhu D; Yang N; Wang Y; Zhang J; Li X; Ren Y; Lu Y
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104093. PubMed ID: 38641030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]